Covid-19. Covid 19 , Virus Identified
Conditions
Interventions
Intervention 1: Intervention group: This group is infected with COVID-19 and receives Annual SZ as a treatment. This medicine is a herbal product obtained from the Sweet wormwood plant (with the scien
Sponsors
Bandare-abbas University of Medical Sciences
Tarbiat Modares University
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Individuals with COVID-19 disease or control group according to specified grouping Both genders from 20 to 50 years old Definite infection with COVID-19 (people whose PCR is positive, HRCT is clear evidence of infection and have common symptoms of moderate disease of Covid-19 Signing an informed consent form
Exclusion criteria
Exclusion criteria: Age less than 20 years and more than 50 years Pregnancy People with cardiac arrhythmia, kidney, liver, metabolic or malignant diseases Mental or skin diseases (rash, dermatitis, psoriasis) Immunodeficiency diseases Acute patient conditions and severe illness, the patient has shortness of breath, blood oxygen drop and the disease is worsening
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune system parameters. Timepoint: Before intervention and 7, 14 days after intervention. Method of measurement: Using flow cytometry and enzyme-linked immunosorbent assay (ELISA) tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoumeh Ebtekar
Tarbiat Modares University
Outcome results
None listed